BY MARLENE BUSKO: Among overweight or obese patients with prediabetes or type 2 diabetes, those who ate 12 eggs/week or more (high-egg diet) had similar blood levels of cardiovascular disease markers as those who ate fewer than 2 eggs/week (low-egg diet) in a year-long study.
“These findings suggest that it is safe for persons at high risk of [type 2 diabetes] and those with [type 2 diabetes] to include eggs, an acceptable and convenient food source, in their diet regularly,” the researchers conclude. (read more)
BY SERENA GORDON: Millions of U.S. seniors can now take part in a Medicare program designed to prevent prediabetes from progressing to type 2 diabetes.
Almost half of Americans 65 and older have prediabetes, and many don’t know it. In addition to an increased risk of type 2 diabetes, prediabetes puts people at risk of heart disease and stroke, according to the American Association of Diabetes Educators. (read more)
BY DR MAX GOMEZ: A new study shows a common vitamin may help slow or even prevent the onset of type 2 diabetes.
It’s vitamin D, better known for its role in helping make strong bones.
Type 2 is by far the most common type of diabetes, with more than 30 million people suffering from it in the United States alone. Sufferers make insulin but their bodies don’t respond to it and eventually their insulin producing cells become exhausted, causing their blood sugar levels to rise. (read more)
BY JACK WOODFIELD: A six-week CrossFit exercise programme led to improved insulin sensitivity and reduced heart disease risk in adults with type 2 diabetes, a study reveals.
CrossFit is a high-intensity endurance and strength training intervention – sessions range between 8-20 minutes – which has expanded in popularity in recent years.
BY ANDREW MASTERSON: An artificial pancreas delivers better outcomes or people with type 1 diabetes than manual injections, according to a review published in the British Medical Journal.
However, the good news is tinged with caution, with both the researchers and the authors of an accompanying editorial warning that most studies testing the devices failed to meet robust standards for evidence.
Artificial pancreas units test blood-sugar levels using a continuous glucose monitor. The monitor sends data to an insulin pump that then calculates the amount of insulin that needs to be injected into the body. (read more)